The store will not work correctly when cookies are disabled.
5-(3,4-Dihydroxy-pyrrolidin-2-yl)-2-methyl-furan-3-carboxylic acid isopropylamide
ID: ALA3350286
PubChem CID: 513284
Max Phase: Preclinical
Molecular Formula: C13H20N2O4
Molecular Weight: 268.31
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1oc([C@H]2NC[C@@H](O)[C@H]2O)cc1C(=O)NC(C)C
Standard InChI: InChI=1S/C13H20N2O4/c1-6(2)15-13(18)8-4-10(19-7(8)3)11-12(17)9(16)5-14-11/h4,6,9,11-12,14,16-17H,5H2,1-3H3,(H,15,18)/t9-,11-,12-/m1/s1
Standard InChI Key: VHRUAYMCMAKGDX-YUSALJHKSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
2.9744 -1.7888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0466 -2.7456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1632 -1.9260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3271 -3.1573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3487 -1.0483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3570 -2.5084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7872 -3.1074 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.5658 -2.8579 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2854 -3.9811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1725 -1.0026 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4909 -4.1850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0416 -3.4943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8995 -0.3619 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.9218 -4.4969 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.1872 -4.9670 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1808 -2.6083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5426 -0.2663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3663 -0.2164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0851 0.4243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 1 1 0
4 2 1 6
5 1 1 0
6 1 2 0
7 6 1 0
8 4 1 0
9 4 1 0
10 5 1 0
11 9 1 0
12 8 1 0
13 5 2 0
9 14 1 6
11 15 1 6
16 6 1 0
17 10 1 0
18 17 1 0
19 17 1 0
2 7 1 0
11 12 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 268.31 | Molecular Weight (Monoisotopic): 268.1423 | AlogP: 0.09 | #Rotatable Bonds: 3 |
Polar Surface Area: 94.73 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.15 | CX Basic pKa: 7.68 | CX LogP: -0.73 | CX LogD: -1.19 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.62 | Np Likeness Score: 0.00 |
References
1. Moreno-Vargas AJ, Demange R, Fuentes J, Robina I, Vogel P.. (2002) Synthesis of [(2S,3S,4R)-3,4-dihydroxypyrrolidin-2-yl]-5-methylfuran-4-carboxylic acid derivatives: new leads as selective beta-galactosidase inhibitors., 12 (17): [PMID:12161128] [10.1016/s0960-894x(02)00397-9] |